KSB Share Price Target 2026, 2027, 2028, 2029, 2030
- Market Cap
- ₹14,908 Cr
- Book Value
- ₹97.5
- Stock P/E
- 56.9
- Dividend Yield
- 0.51%
- ROE
- 18.4%
- ROCE
- 24.7%
- PEG Ratio
- 2.25
- EV/EBITDA
- 35.4
Fundamentals from Screener.in, as of 5 Aug 2026. Live price via Yahoo Finance.
KSB share price today
KSB (NSE: KSB) makes pumps and valves — energy, water, industry, buildings — with one credential that separates it from every domestic rival: nuclear qualification. Its primary-coolant pumps sit inside India’s pressurised heavy-water reactors, a certification lineage (with the German KSB parent’s technology) that took decades of audits to earn and that India’s announced nuclear expansion — a fleet of new reactors through the 2030s — will pay for handsomely. Our internal note is direct: the fleet of Indian reactors to come needs exactly this.
The broader business rides energy and water capex with 25.3% five-year profit CAGR, 24.7% ROCE and zero debt. At 56.9×, our universe tags it wait: the nuclear option is real, and the market has already bought a ticket.
Pumps for the hardest jobs
Nuclear is the crown, not the volume: standard energy (thermal, oil & gas), water infrastructure and industrial pumps fund the P&L while reactor orders arrive in policy-sized lumps. The parent’s technology transfer covers the premium end (high-pressure, high-temperature applications), and the services/spares annuity on installed pumps smooths the cycles. Zero debt keeps the optionality costless to hold.
Watch-items: nuclear tender timelines (the multiplier event, on government time), thermal/water capex cycles, competition from Kirloskar Brothers and imports at the commodity end, and margin mix as nuclear scales.
The numbers
From our research universe snapshot (5 Aug 2026):
| Metric | Value |
|---|---|
| Market cap | ₹14,908 Cr |
| P/E (TTM) | 56.9 |
| EV/EBITDA | 35.4 |
| Operating margin | 12.7% |
| ROE / ROCE | 18.4% / 24.7% |
| Debt to equity | 0.00 |
| Sales CAGR (5y) | 17.4% |
| Profit CAGR (5y) | 25.3% |
| Promoter holding | 69.8% |
| EPS (TTM) | ₹15.06 |
KSB share price target 2026 to 2030
EPS base ₹15.06 (TTM). Bear: nuclear slips a full cycle — 9% growth, multiple at 32×. Base: capex compounds, first fleet orders land — 15% growth at 44×. Bull: the reactor programme converts at scale — 20% growth at 56×.
| Year | Bear (32×, +9%) | Base (44×, +15%) | Bull (56×, +20%) |
|---|---|---|---|
| 2026 | ₹525 | ₹762 | ₹1,010 |
| 2027 | ₹573 | ₹876 | ₹1,215 |
| 2028 | ₹624 | ₹1,010 | ₹1,455 |
| 2029 | ₹680 | ₹1,160 | ₹1,750 |
| 2030 | ₹741 | ₹1,335 | ₹2,100 |
From ₹857, the base case is ≈ +56% over four and a half years; the bear is −13%. Policy options priced at 57× reward disciplined entries only — the range below is that discipline.
Reasons to own KSB (at the right price)
- Nuclear qualification — a decades-deep moat exactly matching India’s reactor plans.
- German parent technology across the premium pump spectrum.
- Zero debt and 25% ROCE while holding the policy option.
- Water and energy capex give the base business structural demand.
- Installed-base spares/services annuity smooths order cycles.
The risks: nuclear tenders run on sovereign timetables, 57× pays today for orders scheduled tomorrow, and the commodity-pump end stays fiercely competitive.
Should you buy at the current price?
The live buy range below is for members — the nuclear option at a civilian price.
FAQ
What is the KSB share price target for 2030? Base case ≈ ₹1,335 (44× on 15% compounded growth), bear ≈ ₹741, bull ≈ ₹2,100. Arithmetic above.
Why does nuclear qualification matter so much? Reactor-coolant pumps are safety-critical, and the approved-vendor list is built on decades of audited performance. India’s announced reactor fleet must buy from that tiny list — KSB is on it.
What does KSB sell outside nuclear? The volume business: pumps and valves for power plants, water and irrigation projects, buildings, and industry — plus the spares and service annuity on everything installed.
When are KSB’s next results? Track the exact date on our results calendar.
This article is research and education, not personalised investment advice. We are not SEBI-registered advisers. Price targets are scenario arithmetic, not promises. Do your own research and consult a registered adviser before acting.